NCT02493036View on ClinicalTrials.gov

A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Irritable Bowel Syndrome With Constipation (IBS-C)

Interventions

DRUG

SYN-010

Trial Locations (11)

33012

Hialeah

33014

Miami Lakes

33126

Miami

33135

Miami

33165

Miami

33166

Miami Springs

33409

West Palm Beach

33614

Tampa

33709

St. Petersburg

Unknown

Virginia Gardens

10016-8202

New York

All Listed Sponsors

lead

Theriva Biologics, Inc.

INDUSTRY

NCT02493036 - A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C | Biotech Hunter | Biotech Hunter